Why CSL, Incitec Pivot, Lake Resources and St Barbara are pushing higher


Image source: Getty Images

In the afternoon discussions, the S&P/ASX 200 Index (ASX:XJO) runs out of steam and begins to slide lower. As of this writing, the benchmark is down 0.4% to 7,012.1 points.

Four ASX shares that do not retain them are listed below. Here’s why they grow taller:

CSL stock price rose 3% to $256.98. Investors bought the shares of this biotherapy giant following reports that the TGA has approved a super flu vaccine by its company Seqirus for children as young as two years old. The Flucelvax Quad vaccine was the first seasonal cell-based influenza vaccine offered in Australia when it was first approved in 2021. Prior to TGA approval, CSL had distributed 100 million doses worldwide.

Incitec Pivot stock price is up nearly 2% at $3.53. This morning, shares of the agricultural chemicals company were updated by Credit Suisse analysts. According to the rating, the broker has put an outperformance rating and a price target of $3.85 on its shares. He thinks Incitec Pivot will benefit from higher fertilizer prices.

Lake Resources’ share price is up 2% at $1.01. This seems to have been prompted by the news that the lithium explorer has raised $39 million thanks to a market increase. Pursuant to its agreement with Acuity Capital, it raised the funds by issuing 40 million shares at 97.5 cents per new share.

the St Barbara Ltd (ASX:SBM) stock price is up 8% at $1.53. Investors bid the gold miner’s shares higher today amid speculation it could be a takeover target. Nearby peers Northern Star Resources Ltd. (ASX:NST) and Ramélius Resources Limited (ASX:RMS) may be interested in the downed gold miner’s Gwalia underground mine and processing plant.

Source link


Comments are closed.